
DuPont de Nemours, Inc. (NYSE:DD) said Friday it agreed to sell its Aramids business, including the Kevlar and Nomex brands, to Arclin, a portfolio company of TJC, L.P., in a deal valued at about $1.8 billion. The transaction is expected to close in the first quarter of 2026, pending regulatory approvals.
At closing, DuPont will receive about $1.2 billion in cash before taxes, a $300 million note, and a 17.5% equity stake in the future Arclin business.